Join our measuringhero Jay on the innovation tour

Experience our latest innovation from the Control fair.

Don't miss ZEISS Quality Innovation Days

Digital event April 15-19, 2024.

Medical plastics insights at Röchling

An exclusive look behind the scenes.

Ossiform: Quality control of 3D printed bone implants

Ossiform chose the GOM Scan 1.

Ukraine war fuels rise of totally resistent bacteria

War-torn Ukraine is not just suffering from hostile attacks from a foreign aggressor, but also from the threat of a totally resistant and contagious bacteria.

Virology professor on the threat from X: ”The next pandemic could be worse“

The question is not if, but when we will be affected by a new unknown virus that causes yet another pandemic. Are we sufficiently prepared? "Absolutely not!", r...

The race between new alzheimer’s drugs Kisunla and Leqembi heats up

Kisunla or Leqembi? The rivalry between Eli Lilly and Bioarctic is intensifying. Where one drug gains approval, the other falls behind. Here's a look at the mar...

The top five most expensive drugs in 2025

New advanced therapeutic medicines are reaching the market, but their price tags remain exceptionally high. This year’s ranking of the most expensive drugs in t...

How Volume EM Advances Life Science Research

Free webinar series.

Learn from Speakers from Leading MedTech Companies

Watch the recordings from ZEISS Quality Innovation Days whenever it suits you.

A new life science cluster formed – “We are very strong in talent”

Stockholm and Uppsala’s joint life science cluster aims to be among the best in Europe. Pontus Holm, Life Science Coordinator for Region Stockholm, says the dec...

Läkemedelsverket till Gisslén: Varje läkare fri att göra egen bedömning

Den avgående statsepidemiologen Magnus Gisslén har ifrågasatt de centorkriterier som Läkemedelsverkets rekommenderar som stöd för att identifiera halsfluss orsa...

The dock that “thinks” for itself

The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...

Säkerhetsbrist i svensk programvara för bröstcancerscreening – kvinna avled

En brist i Sectras programvara ledde till att en kvinna med bröstcancer fick ett felaktigt besked. Hon avled senare. Programmet används i 20 av 21 regioner i Sv...

The new Swedish life science strategy – “It will consolidate Sweden as a leader”

Clinical trials and precision health are emphasised as key areas in the new national life science strategy.

Biogens sparpaket – tusen jobb ska bort

Det är tuffa tider för det amerikanska biotechbolaget Biogen. Nu aviseras kraftiga besparingar och var nionde jobb på företaget väntas försvinna.

Thermo Fisher köper Solventum-enhet för över 4 miljarder dollar

Förvärvet berör Solventums enhet för teknologier inom rening och filter som används vid tillverkningsprocesser.

Gasfylld termometer för hygieniska processer

Inom industrier där hygien och noggrannhet är avgörande – som läkemedels-, livsmedels- samt färg- och lacktillverkning – krävs instrument som uppfyller höga sta...

Festo liquid dispensing: going fast and slow

Dispensing liquid with Festo equipment developed for automation can really be adapted to your needs

Behöver du vätskekylning under noll grader?

SMC erbjuder cirkulationskylare för en rad olika appikationer och temperaturer, minusgrader inkluderat. Kontakta oss så hittar vi rätt lösning för dig!

“We should avoid surgery if we can”

Since February this year, she has been Scientific Director Life Science at the Karolinska Institutet. Life Science Sweden met Anna Martling for a talk about rol...

Hypothesis testing versus conspiracy theory

"How do you know what is a conspiracy theory and what is a reasonable, scientifically based conclusion?" In a column, Ingrid Lönnstedt reflects on this question.

Amrop Malmö AB

After the threat of tariffs – Novartis invests 230 billion in the USA

Pharmaceutical giant Novartis plans to invest 23 billion dollarsover the next five years to expand its production in the USA. The goal is for all medicines dest...